These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29929757)

  • 21. Adrenal and extra-adrenal nonfunctioning composite pheochromocytoma/paraganglioma with immunohistochemical ectopic hormone expression: comparison of two cases.
    Gong J; Wang X; Chen X; Chen N; Huang R; Lu C; Chen D; Zeng H; Zhou Q
    Urol Int; 2010; 85(3):368-72. PubMed ID: 20829582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pheochromocytomas in adrenal medulla or extra-adrenal and multiple endocrine neoplasms:a clinicopathologic analysis of 181 cases].
    Jiang CX; Zeng Z; Wang T; Liu X; Liu R; Li Y
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):762-6. PubMed ID: 22336161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters.
    van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ
    J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathology of pheochromocytoma and extra-adrenal paraganglioma.
    Tischler AS; Kimura N; Mcnicol AM
    Ann N Y Acad Sci; 2006 Aug; 1073():557-70. PubMed ID: 17102124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignant pheochromocytoma: predictive factors of malignancy and clinical course in 16 patients at a single tertiary medical center.
    Szalat A; Fraenkel M; Doviner V; Salmon A; Gross DJ
    Endocrine; 2011 Apr; 39(2):160-6. PubMed ID: 21069578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors.
    Babic B; Patel D; Aufforth R; Assadipour Y; Sadowski SM; Quezado M; Nilubol N; Prodanov T; Pacak K; Kebebew E
    Surgery; 2017 Jan; 161(1):220-227. PubMed ID: 27865588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors.
    Kimura N; Watanabe T; Noshiro T; Shizawa S; Miura Y
    Endocr Pathol; 2005; 16(1):23-32. PubMed ID: 16000843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertensive Crisis during Microwave Ablation of Adrenal Neoplasms: A Retrospective Analysis of Predictive Factors.
    Zheng L; Zhou F; Yu X; Liang P; Cheng Z; Han Z; Yu J; Liu F; Wang W
    J Vasc Interv Radiol; 2019 Sep; 30(9):1343-1350. PubMed ID: 31155498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy.
    Fujiwara Y; Ohmoto A; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Yuasa T; Yonese J; Takahashi S
    Endocr J; 2021 Jun; 68(6):671-681. PubMed ID: 33518616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the largest single-institutional experience.
    Ayala-Ramirez M; Feng L; Habra MA; Rich T; Dickson PV; Perrier N; Phan A; Waguespack S; Patel S; Jimenez C
    Cancer; 2012 Jun; 118(11):2804-12. PubMed ID: 22006217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
    Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
    Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
    Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic tests and biomarkers for pheochromocytoma and extra-adrenal paraganglioma: from routine laboratory methods to disease stratification.
    Eisenhofer G; Tischler AS; de Krijger RR
    Endocr Pathol; 2012 Mar; 23(1):4-14. PubMed ID: 22180288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma.
    Wang Y; Yu X; Huang Y
    Front Endocrinol (Lausanne); 2022; 13():853878. PubMed ID: 35355563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
    Amar L; Baudin E; Burnichon N; Peyrard S; Silvera S; Bertherat J; Bertagna X; Schlumberger M; Jeunemaitre X; Gimenez-Roqueplo AP; Plouin PF
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3822-8. PubMed ID: 17652212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy.
    McBride JF; Atwell TD; Charboneau WJ; Young WF; Wass TC; Callstrom MR
    J Vasc Interv Radiol; 2011 Sep; 22(9):1263-70. PubMed ID: 21856504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypertension, catecholamine hypersecretion and potential for metastasis: recent progress in the pathophysiology and genetics of pheochromocytoma and paraganglioma].
    Plouin PF; Amar L; Gimenez-Roqueplo AP
    Bull Acad Natl Med; 2015; 199(2-3):313-9. PubMed ID: 27476312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.
    Lam AK
    Endocr Pathol; 2017 Sep; 28(3):213-227. PubMed ID: 28477311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnosis and surgical treatment of extra-adrenal pheochromocytoma].
    Hiller WF; Scheumann GF; Dralle H
    Chirurg; 1993 Jan; 64(1):36-42. PubMed ID: 8436047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
    Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
    Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.